Sartorius Stedim Biotech SA
PAR:DIM
Wall Street
Price Targets
DIM Price Targets Summary
Sartorius Stedim Biotech SA
According to Wall Street analysts, the average 1-year price target for
DIM
is 239.39 EUR
with a low forecast of 212.1 EUR and a high forecast of 263.55 EUR.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Sartorius Stedim Biotech SA
For the last 13 years the
compound annual growth rate for
Sartorius Stedim Biotech SA's operating income is
13%.
The projected
CAGR
for the next 3 years is
32%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DIM's stock price target?
Price Target
239.39
EUR
According to Wall Street analysts, the average 1-year price target for
DIM
is 239.39 EUR
with a low forecast of 212.1 EUR and a high forecast of 263.55 EUR.
What is Sartorius Stedim Biotech SA's Revenue forecast?
Projected CAGR
11%
For the last 13 years the
compound annual growth rate for
Sartorius Stedim Biotech SA's revenue is
15%.
The projected
CAGR
for the next 3 years is
11%.
What is Sartorius Stedim Biotech SA's Operating Income forecast?
Projected CAGR
32%
For the last 13 years the
compound annual growth rate for
Sartorius Stedim Biotech SA's operating income is
13%.
The projected
CAGR
for the next 3 years is
32%.
What is Sartorius Stedim Biotech SA's Net Income forecast?
Projected CAGR
54%
For the last 13 years the
compound annual growth rate for
Sartorius Stedim Biotech SA's net income is
11%.
The projected
CAGR
for the next 3 years is
54%.
You don't have any saved screeners yet
